FXR agonist

0 marketed 1 in Phase 3 1 in Phase 1

This page covers all FXR agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting FXR.

Targets

Phase 3 pipeline (1)

norUrsodeoxycholic acid · Dr. Falk Pharma GmbH · Liver disease
NorUrsodeoxycholic acid is a bile acid that acts as an FXR agonist.

Phase 1 pipeline (1)

ASC42 · Gannex Pharma Co., Ltd. · Gastroenterology
ASC42 is a potent and selective FXR agonist that modulates bile acid metabolism and inflammation.